Evidence map›Paper›PMID 27042261›Full record

ArticleOxidative medicine and cellular longevity2016

Phlorizin, an Active Ingredient of Eleutherococcus senticosus, Increases Proliferative Potential of Keratinocytes with Inhibition of MiR135b and Increased Expression of Type IV Collagen.

Hye-Ryung Choi, Kyung-Mi Nam, Hyun-Sun Lee, Seung-Hye Yang, Young-Soo Kim, Jongsung Lee, Akira Date, Kazumi Toyama, Kyoung-Chan Park

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Anti-Neuroinflammatory Effects of Compounds Isolated fromMolecules (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Frontiers in pharmacology · 2025
    Review
  4. Review
  5. Plants (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Antioxidants as an Epidermal Stem Cell Activator.Antioxidants (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Hye-Ryung ChoiDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi 463-707, Republic of Korea.
Kyung-Mi NamDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi 463-707, Republic of Korea.
Hyun-Sun LeeDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi 463-707, Republic of Korea.
Seung-Hye YangDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi 463-707, Republic of Korea.
Young-Soo KimBiospectrum Life Science Institute, Seongnam, Gyeonggi 462-807, Republic of Korea.
Jongsung LeeDepartment of Genetic Engineering, Sungkyunkwan University, 2066 Seobu-ro, Suwon City, Gyunggi Do 164-19, Republic of Korea.
Akira DateDepartment of Medical Pharmacy, Hyogo University of Health Sciences, Kobe 650-8530, Japan.
Kazumi ToyamaP&G Group, Kobe 658-0032, Japan.
Kyoung-Chan ParkDepartment of Dermatology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi 463-707, Republic of Korea.
Seoul National University Bundang Hospital · KRLife Science Institute · JPSungkyunkwan University · KRUniversity of Health Sciences · SO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E. senticosus extract (ESE), known as antioxidant, has diverse pharmacologic effects. It is also used as an antiaging agent for the skin and phlorizin (PZ) is identified as a main ingredient. In this study, the effects of PZ on epidermal stem cells were investigated. Cultured normal human keratinocytes and skin equivalents are used to test whether PZ affects proliferative potential of keratinocytes and how it regulates these effects. Skin equivalents (SEs) were treated with ESE and the results showed that the epidermis became slightly thickened on addition of 0.002% ESE. The staining intensity of p63 as well as proliferating cell nuclear antigen (PCNA) is increased, and integrin α6 was upregulated. Analysis of ESE confirmed that PZ is the main ingredient. When SEs were treated with PZ, similar findings were observed. In particular, the expression of integrin α6, integrin β1, and type IV collagen was increased. Levels of mRNA for type IV collagen were increased and levels of miR135b were downregulated. All these findings suggested that PZ can affect the proliferative potential of epidermal cells in part by microenvironment changes via miR135b downregulation and following increased expression of type IV collagen.

Indexed as

AnimalsAntioxidantsCell ProliferationCells, CulturedCollagen Type IVEleutherococcusGene Expression RegulationHumansKeratinocytesMicroRNAsPhlorhizinRatsSkinAntioxidantsCollagen Type IVMicroRNAsMIRN135 microRNA, ratPhlorhizin

Identifiers

PMID27042261
PMCPMC4799823
OpenAlexW2290024857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.